Skip to main content

Global Selector

Immunology
Hematology
Respiratory

CSL Behring Events

Immunology
Hematology
Respiratory

Immunology
Hematology
Respiratory
Global Selector

CSL Behring supports the International Society on Thrombosis and Haemostasis annual congress.

ISTH 2023

This information was developed for the audience of a Congress that took place in Montreal, Canada. Gene therapy for hemophilia B is not approved or for sale in Canada. Before prescribing any product, always refer to the local materials such as the Prescribing Information, Product Monograph, and/or the Summary of Product Characteristics in your country.

CSL Behring Events
Hematology
ISTH 2023

Click to review resources

Gene Therapy in Hemophilia B

Duration: 00:02:55

Gene Therapy for treating disease

Gene Therapy for Treating Disease

Gene Therapy: A Primer

Gene Therapy: A Primer

Immunogenicity in Gene Therapy: A Primer

Immunogenicity in Gene Therapy: A Primer

CMD-HGX-0019
June 2023

Contact Terms of Use Accessibility Statement Privacy Policy Cookie Policy Sitemap

Contact
Terms of Use
Accessibility Statement
Privacy Policy
Cookie Policy
Sitemap

CSL, All Rights Reserved © 2026